Healthcare & Medical Devices Global On demand · 24-48h

Global SNP Genotyping and Analysis Market Strategic Research Report

Global SNP Genotyping and Analysis Market Strategic Research…
$3,500 USD
Market Research Reports
Strategic Research Report
Global SNP Genotyping and Analysis Market
$2.22B2025
16.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Dynamic Allele-Specific Hybridization, Molecular Beacons, SNP Microarrays

By Application: Pharmaceuticals and Pharmacogenomics, Diagnostic Research, Agricultural Biotechnology, Breeding and Animal Livestock

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, Illumina, Agilent Technologies, Roche, Bio-rad, LGC, Sequenom, Beckman Coulter, QIAGEN, Fluidigm

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 88 pages
Market size 2025
$2.22B
Billion USD
Forecast CAGR
16.4%
2025-2032
Forecast 2032
$6.4B
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global SNP Genotyping and Analysis market size is predicted to grow from US$ 2,219 million in 2025 to US$ 6,354 million in 2032; it is expected to grow at a CAGR of 16.4% from 2026 to 2032.

A SNP is a single base pair mutation that occurs at a specific site in the DNA sequence. There are usually two variations, or alleles, with one occurring only in between 1% to 5% of the population. On average, two humans, DNA sequences differ in more than three million positions. In some cases, this variation results in the one minor allele causing or predisposing the individual to have a certain disease or trait. The SNP Genotyping and Analysis industry can be broken down into several segments, Dynamic Allele-Specific Hybridization, Molecular Beacons, SNP Microarrays, etc.

Global key players of SNP genotyping and analysis include Thermo Fisher Scientific, Illumina, Agilent Technologies, Roche, Bio-rad, etc. Global top five manufacturers hold a share over 87%. The key players are mainly located in Europe and North America. In terms of product, dynamic allele-Specific hybridization is the largest segment, with a share over 48%. And in terms of application, the largest application is pharmaceuticals and pharmacogenomics, with a share over 52%.

This report presents a comprehensive overview of the global SNP Genotyping and Analysis market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Dynamic Allele-Specific Hybridization
  • Molecular Beacons
  • SNP Microarrays

Segment by players, this report covers

  • Thermo Fisher Scientific
  • Illumina
  • Agilent Technologies
  • Roche
  • Bio-rad
  • LGC
  • Sequenom
  • Beckman Coulter
  • QIAGEN
  • Fluidigm

Segment by Application

  • Pharmaceuticals and Pharmacogenomics
  • Diagnostic Research
  • Agricultural Biotechnology
  • Breeding and Animal Livestock

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global SNP Genotyping and Analysis market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pharmaceuticals and Pharmacogenomics, Diagnostic Research, Agricultural Biotechnology evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global SNP Genotyping and Analysis Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 16.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.22B
2025
Forecast
$6.4B
2032
CAGR
16.4%
2025–2032
Régions
5
global
Key companies
Thermo Fisher ScientificIlluminaAgilent TechnologiesRocheBio-radLGCSequenomBeckman Coulter
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Dynamic Allele-Specific HybridizationMolecular BeaconsSNP Microarrays
By Application
Pharmaceuticals and PharmacogenomicsDiagnostic ResearchAgricultural BiotechnologyBreeding and Animal Livestock

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Dynamic Allele-Specific Hybridization
  • 3.1.3 Molecular Beacons
  • 3.1.4 SNP Microarrays
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pharmaceuticals and Pharmacogenomics
  • 4.1.3 Diagnostic Research
  • 4.1.4 Agricultural Biotechnology
  • 4.1.5 Breeding and Animal Livestock
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Illumina
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Agilent Technologies
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Roche
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Bio-rad
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 LGC
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Sequenom
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Beckman Coulter
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 QIAGEN
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Fluidigm
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global SNP Genotyping and Analysis market size?
The global SNP Genotyping and Analysis market is estimated at US$ 2.22 billion in 2025 (base year) and is projected to reach US$ 6.35 billion by 2032.
What growth rate is expected for the SNP Genotyping and Analysis market through 2032?
The market is expected to grow at a CAGR of 16.4% from 2026 to 2032, expanding from US$ 2.22 billion in 2025 to US$ 6.35 billion in 2032, roughly 2.9 times its base-year value.
How is SNP Genotyping and Analysis defined?
A SNP is a single base pair mutation that occurs at a specific site in the DNA sequence. There are usually two variations, or alleles, with one occurring only in between 1% to 5% of the population. On average, two humans, DNA sequences differ in more than three million positions.
What are the main segments of the SNP Genotyping and Analysis market by type?
By type, the market is segmented into Dynamic Allele-Specific Hybridization, Molecular Beacons and SNP Microarrays.
Which applications drive demand in the SNP Genotyping and Analysis market?
Key applications covered include Pharmaceuticals and Pharmacogenomics, Diagnostic Research, Agricultural Biotechnology and Breeding and Animal Livestock.
Who are the key players in the SNP Genotyping and Analysis market?
Key players profiled include Thermo Fisher Scientific, Illumina, Agilent Technologies, Roche, Bio-rad, LGC, Sequenom and Beckman Coulter, among 10 companies covered in total.
Which regions and countries are covered for SNP Genotyping and Analysis?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the SNP Genotyping and Analysis market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pharmaceuticals and Pharmacogenomics, Diagnostic Research and Agricultural Biotechnology, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the SNP Genotyping and Analysis market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.